{"id":1357,"date":"2006-02-10T23:07:44","date_gmt":"2006-02-11T04:07:44","guid":{"rendered":"http:\/\/framingham.com\/wordpress\/?p=1357"},"modified":"2010-04-17T19:41:51","modified_gmt":"2010-04-18T00:41:51","slug":"clinical-trials-at-metrowest-medical-center","status":"publish","type":"post","link":"https:\/\/www.framingham.com\/news\/2006\/02\/10\/health-fitness\/clinical-trials-at-metrowest-medical-center\/","title":{"rendered":"Clinical Trials at Metrowest Medical Center"},"content":{"rendered":"

FRAMINGHAM, MA<\/strong> - The final phase of drug or medical therapy testing usually involves \"clinical trials\" -- testing on human beings who volunteer to participate.<\/p>\n

The U.S. National Institute of Health closely monitors these trials and publishes information about such programs on their www.ClinicalTrials.gov website.<\/p>\n

Metrowest Medical Center, (the former \"Framingham Union Hospital<\/em>\"), hosts several cancer related trials. A recent search of the site found several trials which are currently recruiting subjects for studies ranging from \"observational\" (no therapy or drug is administered, subjects are examined or monitored in hopes of discovering new information about a particular medical study), to clinical trials for as-yet (FDA) unapproved therapies or medicines.<\/p>\n

If you are interested in participating, it is suggested that you first visit the www.ClinicalTrials.com website and review the criteria for participants, then consult your doctor before contacting the recruiter for a particular trial.<\/p>\n

Below is a list of some of the trials which are currently recruiting in Framingham:<\/em><\/p>\n

Radiation Therapy With or Without Optional
\nTamoxifen in Treating Women With Ductal
\nCarcinoma in Situ<\/strong>
\nContact: Teresa A. Van Buren, MD 508-383-1260
\n(Trial ID#: NCT00003857)<\/em><\/p>\n

Radiation Therapy in Preventing CNS Metastases
\nin Patients With Non-Small Cell Lung Cancer<\/strong>
\nContact: Allison H. Sacher, MD 508-383-1000
\n(Trial ID#: NCT00048997)<\/em><\/p>\n

Anastrozole Compared With Tamoxifen After
\nLumpectomy in Treating Postmenopausal Women
\nWith Ductal Carcinoma in Situ<\/strong>
\nContact: Madhavi L. Venigalla, MD 508-383-1000
\n(Trial ID#: NCT00053898)<\/em><\/p>\n

Radiation Therapy With Either Capecitabine or
\nFluorouracil Before Surgery in Treating Patients
\nWith Resectable Rectal Cancer<\/strong>
\nContact: Madhavi L. Venigalla, MD 508-383-1000
\n(Trial ID#: NCT00058474)<\/em><\/p>\n

Suppression of Ovarian Function Plus Either Tamoxifen or
\nExemestane Compared With Tamoxifen Alone in Treating
\nPremenopausal Women With Hormone-Responsive Breast Cancer<\/strong>
\nContact: Madhavi L. Venigalla, MD 508-383-1000
\n(Trial ID#: NCT00066690)<\/em><\/p>\n

Comparison of Combination Chemotherapy Regimens
\nWith or Without Cetuximab in Treating Patients Who
\nHave Undergone Surgery For Stage III Colon Cancer<\/strong>
\nContact: Madhavi L. Venigalla, MD 508-383-1000
\n(Trial ID#: NCT00079274)<\/em><\/p>\n

Combination Chemotherapy in Treating Women Who Have
\nUndergone Surgery for Node-Positive Breast Cancer<\/strong>
\nContact: Madhavi L. Venigalla, MD 508-383-1000
\n(Trial ID#: NCT00093795)<\/em><\/p>\n

Docetaxel and Prednisone With or Without Bevacizumab
\nin Treating Patients With Prostate Cancer That Did Not
\nRespond to Hormone Therapy<\/strong>
\nContact: John G. Krikorian 508-383-1000
\n(Trial ID#: NCT00110214)
\n<\/em><\/p>\n

For more information visit: www.clinicaltrials.gov<\/a><\/em><\/p>\n

###<\/p>\n","protected":false},"excerpt":{"rendered":"

FRAMINGHAM, MA – The final phase of drug or medical therapy testing usually involves “clinical trials” — testing on human beings who volunteer to participate. The U.S. National Institute of Health closely monitors these trials and publishes information about such programs on their www.ClinicalTrials.gov website. Metrowest Medical Center, (the former “Framingham Union Hospital”), hosts several cancer related… [read more]<\/a>.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[718,404,716,713,719,715,717,712,714],"class_list":["post-1357","post","type-post","status-publish","format-standard","hentry","category-health-fitness","tag-anastrozole","tag-cancer","tag-capecitabine","tag-clinical-trials","tag-drug-therapy","tag-exemestane","tag-fluorouracil","tag-meds","tag-tamoxifen"],"_links":{"self":[{"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/posts\/1357","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/comments?post=1357"}],"version-history":[{"count":1,"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/posts\/1357\/revisions"}],"predecessor-version":[{"id":1358,"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/posts\/1357\/revisions\/1358"}],"wp:attachment":[{"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/media?parent=1357"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/categories?post=1357"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.framingham.com\/news\/wp-json\/wp\/v2\/tags?post=1357"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}